Pragati Singh

491 total citations
31 papers, 375 citations indexed

About

Pragati Singh is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Pragati Singh has authored 31 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in Pragati Singh's work include Liver Disease Diagnosis and Treatment (6 papers), Diet, Metabolism, and Disease (5 papers) and Adipose Tissue and Metabolism (5 papers). Pragati Singh is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Diet, Metabolism, and Disease (5 papers) and Adipose Tissue and Metabolism (5 papers). Pragati Singh collaborates with scholars based in India and New Zealand. Pragati Singh's co-authors include Jiaur R. Gayen, Syed Anees Ahmed, Athar Husain, Mohammad Irshad Reza, Anand P. Gupta, Mohammed Riyazuddin, Sanjana Kumariya, Kashif Hanif, Guru R. Valicherla and Zakir Hossain and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Pragati Singh

29 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pragati Singh India	12	142	91	86	78	34	31	375
Azam Moslehi Iran	13	146 1.0×	82 0.9×	57 0.7×	122 1.6×	27 0.8×	30	461
Vigneshwaran Pitchaimani Japan	14	162 1.1×	67 0.7×	61 0.7×	55 0.7×	25 0.7×	23	551
Zuzana Papáčková Czechia	9	154 1.1×	61 0.7×	86 1.0×	117 1.5×	29 0.9×	14	442
Qingwei Chen China	13	192 1.4×	38 0.4×	105 1.2×	71 0.9×	37 1.1×	39	478
Dongxu Fu United States	11	187 1.3×	83 0.9×	41 0.5×	92 1.2×	63 1.9×	23	597
Heaji Lee South Korea	11	101 0.7×	65 0.7×	79 0.9×	56 0.7×	31 0.9×	25	340
Mehrnaz Abbasi United States	13	91 0.6×	54 0.6×	98 1.1×	70 0.9×	29 0.9×	25	376
Lisa Rodrigues Portugal	12	126 0.9×	134 1.5×	128 1.5×	100 1.3×	21 0.6×	25	533
Ameng Shi China	7	168 1.2×	51 0.6×	49 0.6×	130 1.7×	23 0.7×	14	467
Linlin Li China	14	223 1.6×	61 0.7×	96 1.1×	53 0.7×	28 0.8×	33	517

Countries citing papers authored by Pragati Singh

Since Specialization

Citations

This map shows the geographic impact of Pragati Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pragati Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pragati Singh more than expected).

Fields of papers citing papers by Pragati Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pragati Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pragati Singh. The network helps show where Pragati Singh may publish in the future.

Co-authorship network of co-authors of Pragati Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Pragati Singh. A scholar is included among the top collaborators of Pragati Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pragati Singh. Pragati Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Pragati, et al.. (2025). Ultrasound-assisted Extraction of Bioactive Compounds from Beetroot (Beta vulgaris L.). Advances in Research. 26(2). 207–213.

Singh, Pragati, et al.. (2024). Characterization and Application of Nanoemulsion in Food Industry: A Review. International Journal of Scientific Research in Science and Technology. 11(6). 672–679. 1 indexed citations

Singh, Pragati, et al.. (2024). A Review of Nanotechnology Applications in Food Processing, Packaging, and Preservation. Advances in Research. 25(6). 427–441. 3 indexed citations

Singh, Pragati, Mohammad Irshad Reza, Syed Anees Ahmed, Athar Husain, & Jiaur R. Gayen. (2023). Pancreastatin deteriorates hepatic lipid metabolism via elevating fetuin B in ovariectomized rats. Biochimie. 214(Pt B). 114–122. 2 indexed citations

Ahmed, Syed Anees, Mohammad Irshad Reza, Athar Husain, et al.. (2022). Evaluation of mutagenic, cytotoxic, mitochondrial dysfunction, apoptotic activity, and acute toxicity of ethanolic extract of Cissus quadrangularis. Toxicology. 483. 153373–153373. 3 indexed citations

Singh, Pragati, et al.. (2021). Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers. Pharmaceutical Development and Technology. 27(1). 95–107. 6 indexed citations

Reza, Mohammad Irshad, Syed Anees Ahmed, Sanjana Kumariya, et al.. (2021). Pancreastatin induces islet amyloid peptide aggregation in the pancreas, liver, and skeletal muscle: An implication for type 2 diabetes. International Journal of Biological Macromolecules. 182. 760–771. 7 indexed citations

Reza, Mohammad Irshad, Syed Anees Ahmed, Pragati Singh, Athar Husain, & Jiaur R. Gayen. (2021). Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning. Life Sciences. 284. 119905–119905. 7 indexed citations

Ahmed, Syed Anees, et al.. (2021). Polyphenolic-rich Cissus quadrangularis extract ameliorates insulin resistance by activating AdipoR1 in peri-/post-menopausal rats. Experimental Gerontology. 159. 111681–111681. 6 indexed citations

10.

Singh, Pragati, et al.. (2021). Pancreastatin mediated regulation of UCP-1 and energy expenditure in high fructose fed perimenopausal rats. Life Sciences. 279. 119677–119677. 12 indexed citations

11.

Ahmed, Syed Anees, Mohammad Irshad Reza, Athar Husain, Pragati Singh, & Jiaur R. Gayen. (2021). Inhibition of NOX4 by Cissus quadrangularis extract protects from Type 2 diabetes induced-steatohepatitis. Phytomedicine Plus. 1(1). 100021–100021. 17 indexed citations

12.

Singh, Pragati, Mohammad Irshad Reza, Syed Anees Ahmed, et al.. (2020). PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis. Heliyon. 6(12). e05826–e05826. 15 indexed citations

13.

Ahmed, Syed Anees, Mohammad Irshad Reza, Sanjana Kumariya, et al.. (2020). Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis. Life Sciences. 257. 118118–118118. 83 indexed citations

14.

Porwal, Konica, Subhashis Pal, Chirag Kulkarni, et al.. (2020). A prebiotic, short-chain fructo-oligosaccharides promotes peak bone mass and maintains bone mass in ovariectomized rats by an osteogenic mechanism. Biomedicine & Pharmacotherapy. 129. 110448–110448. 31 indexed citations

15.

Singh, Pragati, Mohammed Riyazuddin, Mohammad Irshad Reza, et al.. (2020). Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice. Heliyon. 6(10). e05133–e05133. 19 indexed citations

16.

Gupta, Anand P., Pragati Singh, Syed Anees Ahmed, et al.. (2020). Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice. European Journal of Pharmacology. 881. 173204–173204. 11 indexed citations

17.

Gupta, Anand P., Syed Anees Ahmed, Pragati Singh, et al.. (2019). Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway. European Journal of Pharmacology. 864. 172723–172723. 21 indexed citations

18.

Porwal, Konica, Subhashis Pal, Shyamsundar Pal China, et al.. (2019). Increased Bone Marrow-Specific Adipogenesis by Clofazimine Causes Impaired Fracture Healing, Osteopenia, and Osteonecrosis Without Extraskeletal Effects in Rats. Toxicological Sciences. 172(1). 167–180. 12 indexed citations

19.

Gupta, Anand P., Pragati Singh, Guru R. Valicherla, et al.. (2019). Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice. Biomedicine & Pharmacotherapy. 116. 108959–108959. 37 indexed citations

20.

Riyazuddin, Mohammed, Guru R. Valicherla, Athar Husain, et al.. (2018). Elucidation of pharmacokinetics of novel DNA ligase I inhibitor, S012-1332 in rats: Integration of in vitro and in vivo findings. Journal of Pharmaceutical and Biomedical Analysis. 162. 205–214. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact